These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 20408745

  • 1. Clinical failure among children with nonsevere community-acquired pneumonia treated with amoxicillin.
    Fontoura MS, Araújo-Neto CA, Andrade SC, Brim RV, Matutino AR, Silva CC, Santana MC, Nobre-Bastos M, Oliveira F, Barreto BB, Santos PM, Noblat L, Cardoso MR, Nascimento-Carvalho CM, PNEUMOPAC-Efficacy Study Group.
    Expert Opin Pharmacother; 2010 Jun; 11(9):1451-8. PubMed ID: 20408745
    [Abstract] [Full Text] [Related]

  • 2. Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children.
    Kogan R, Martínez MA, Rubilar L, Payá E, Quevedo I, Puppo H, Girardi G, Castro-Rodriguez JA.
    Pediatr Pulmonol; 2003 Feb; 35(2):91-8. PubMed ID: 12526069
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Placebo vs Amoxicillin for Nonsevere Fast-Breathing Pneumonia in Malawian Children Aged 2 to 59 Months: A Double-blind, Randomized Clinical Noninferiority Trial.
    Ginsburg AS, Mvalo T, Nkwopara E, McCollum ED, Ndamala CB, Schmicker R, Phiri A, Lufesi N, Izadnegahdar R, May S.
    JAMA Pediatr; 2019 Jan 01; 173(1):21-28. PubMed ID: 30419120
    [Abstract] [Full Text] [Related]

  • 7. Cefuroxime compared to amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia.
    Oh HM, Ng AW, Lee SK.
    Singapore Med J; 1996 Jun 01; 37(3):255-7. PubMed ID: 8942221
    [Abstract] [Full Text] [Related]

  • 8. Pneumonia.
    Kabra SK, Singhal T, Lodha R.
    Indian J Pediatr; 2001 Jul 01; 68 Suppl 3():S19-23. PubMed ID: 11980455
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of 3-day versus 5-day antibiotic therapy for clinically diagnosed nonsevere pneumonia in children from developing countries.
    Sutijono D, Hom J, Zehtabchi S.
    Eur J Emerg Med; 2011 Oct 01; 18(5):244-50. PubMed ID: 21394031
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of intramuscular penicillin versus oral amoxicillin in the early treatment of outpatient pediatric pneumonia.
    Tsarouhas N, Shaw KN, Hodinka RL, Bell LM.
    Pediatr Emerg Care; 1998 Oct 01; 14(5):338-41. PubMed ID: 9814400
    [Abstract] [Full Text] [Related]

  • 11. [Importance of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired pneumonia].
    Sáez-Llorens X, Castaño E, Wubbel L, Castrejón MM, de Morales I, Vallarino D, de Atencio I, Muñiz L, Olsen K, McCracken GH.
    Rev Med Panama; 1998 Sep 01; 23(2):27-33. PubMed ID: 11214557
    [Abstract] [Full Text] [Related]

  • 12. Pneumonia: macrolides or amoxicillin for community acquired pneumonia?
    Marchetti F, Berti I.
    BMJ; 2006 May 20; 332(7551):1213-4. PubMed ID: 16710005
    [No Abstract] [Full Text] [Related]

  • 13. Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia.
    Bradley JS, Arguedas A, Blumer JL, Sáez-Llorens X, Melkote R, Noel GJ.
    Pediatr Infect Dis J; 2007 Oct 20; 26(10):868-78. PubMed ID: 17901791
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
    Ye X, Sikirica V, Schein JR, Grant R, Zarotsky V, Doshi D, Benson CJ, Riedel AA.
    Clin Ther; 2008 Feb 20; 30(2):358-71. PubMed ID: 18343274
    [Abstract] [Full Text] [Related]

  • 16. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
    Canani RB, Cirillo P, Roggero P, Romano C, Malamisura B, Terrin G, Passariello A, Manguso F, Morelli L, Guarino A, Working Group on Intestinal Infections of the Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP).
    Pediatrics; 2006 May 20; 117(5):e817-20. PubMed ID: 16651285
    [Abstract] [Full Text] [Related]

  • 17. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M, Chevalier I, Sterescu A, Bergeron S, Brunet S, Taddeo D.
    Pediatrics; 2004 Oct 20; 114(4):e469-76. PubMed ID: 15466073
    [Abstract] [Full Text] [Related]

  • 18. Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study.
    File TM, Mandell LA, Tillotson G, Kostov K, Georgiev O.
    J Antimicrob Chemother; 2007 Jul 20; 60(1):112-20. PubMed ID: 17537866
    [Abstract] [Full Text] [Related]

  • 19. Comparison of oral amoxicillin with placebo for the treatment of world health organization-defined nonsevere pneumonia in children aged 2-59 months: a multicenter, double-blind, randomized, placebo-controlled trial in pakistan.
    Hazir T, Nisar YB, Abbasi S, Ashraf YP, Khurshid J, Tariq P, Asghar R, Murtaza A, Masood T, Maqbool S.
    Clin Infect Dis; 2011 Feb 01; 52(3):293-300. PubMed ID: 21189270
    [Abstract] [Full Text] [Related]

  • 20. A cost-effectiveness analysis of antimicrobial treatment of community-acquired pneumonia taking into account resistance in Belgium.
    Martin M, Moore L, Quilici S, Decramer M, Simoens S.
    Curr Med Res Opin; 2008 Mar 01; 24(3):737-51. PubMed ID: 18230196
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.